Proteins could help women avoid thyroid surgery

September 12, 2011

AUGUSTA, Ga. - Dr. Paul Weinberger wants to make thyroid cancer diagnosis as simple and accurate as checking for high cholesterol.

About 30 percent of women have a thyroid growth in their lifetime, the vast majority of which is not cancer, said Weinberger, otolaryngologist at Georgia Health Sciences University. In about 80 percent of cases, physicians can rule out cancer based on the shape of biopsied thyroid cells.

It's the remaining 20 percent that are problematic: 75 percent are benign but there is no way to be sure without surgery.

"The vast majority of patients who get this indeterminate answer end up having at least part of their thyroid gland removed," Weinberger said. "And we end up saying afterward: 'Oh, good news, this was not cancer.'"

Weinberger wants to help women avoid unnecessary surgery with the help of a Young Investigator Combined Award from the American Head and Neck Society/American Academy Otolaryngology-Head and Neck Surgery Foundation.

"That is the Holy Grail everybody is looking for: blood-based biomarkers of cancer," Weinberger said.

He's looking at two proteins, Galectin-3 and HBME-1, about which little is known other than they are found at elevated levels in thyroid cancer. While still a resident at GHSU, Weinberger was honored by the Head and Neck Society for his role in linking Galectin-3 to thyroid cancer. Three years ago GHSU and other centers started checking Galectin-3 levels as part a definitive cancer diagnosis in surgically removed thyroid tissue. More recently, HBME-1testing also was added.

But Weinberger believes those proteins could tell the tale much earlier as biomarkers in the few cells removed during a needle biopsy. Using super-sensitive mass spectrometry technology developed to detect trace amounts of drugs and other substances in forensic pathology and now used in major research centers, he'll examine the biopsied cells collected over three years from 50 patients to look at levels of both proteins. He can then correlate those with pathology findings from the surgically removed thyroid. He's tested the concept in purified proteins and some cell lines. If the relationship holds that elevated protein levels equal cancer in the patient samples, the next step would be a prospective study in current patients before seeking Food and Drug Administration approval.

He's stored the existing samples at room temperature to make sure the proteins are stable enough to be functional biomarkers so that referring physicians, for example, could one day send tissue samples to centers such as GHSU with mass spectrometry capabilities.

Weinberger noted that even benign thyroid growths sometimes necessitate surgery because of airway and/or swallowing problems. An ultrasound of the growth determines whether a biopsy is needed.

While the cause of thyroid disease is essentially unknown, the thyroid is one of the most metabolically active areas of the body; it receives as much blood flow as the brain and constantly produces hormones essential to regulating the metabolism, Weinberger said.
-end-


Medical College of Georgia at Augusta University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.